HRMY
Harmony Biosciences Holdings, Inc.Company with tickers: HRMY
CIK
1802665
CUSIP
413197104
Shares Outstanding
57,892,676
13F Activity (30d)
16 filings
13 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$200,000,000
as of 2023-10-31
Remaining Authorization
$150,000,000
as of 2026-03-31
Program Utilization
25.0%
$50,000,000 used of $200,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2023-12-31 | $100,000,000 | 10-K, filed 2026-02-24 |
| 2020-12-31 | $167,000 | 10-K, filed 2023-02-21 |